When should the clinician suspect antimicrobial resistance in the setting of MAC lung disease? How is this confirmed?

When should the clinician suspect antimicrobial resistance in the setting of MAC lung disease? How is this confirmed?

When should the clinician suspect antimicrobial resistance in the setting of MAC lung disease? How is this confirmed?


Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | NTM-Pulmonary Infection Intelligence Zone

Presenter

Julie Philley, MD

Julie Philley, MD

Chair of the Department of Medicine
Chief of Pulmonary and Critical Care
UT Health North Campus Tyler
The University of Texas Health Sciences Center
Houston, Texas